Anna Mutti

Dynorphin‐based “release on demand” gene therapy for drug‐resistant temporal lobe epilepsy

Alexandra S. Agostinho, Mario Mietzsch, Luca Zangrandi et al. · EMBO Molecular Medicine · 2019 · 51 citations · Full text

The modulation of BDNF expression and signalling dissects the antidepressant from the reinforcing properties of ketamine: Effects of single infusion vs. chronic self-administration in rats

Lucia Caffino, Marzia Di Chio, Giuseppe Giannotti et al. · Pharmacological Research · 2015 · 33 citations

Bdnf Expression, Psychoactive Drug, Psychiatry +12

Nicotine-seeking reinstatement is reduced by inhibition of instrumental memory reconsolidation

Vincenzo Tedesco, Anna Mutti, Alessia Auber et al. · Behavioural Pharmacology · 2014 · 33 citations

Memory Retrieval, Behavioral Addiction, Relapse Prevention +17

Pharmacological and non-pharmacological factors that regulate the acquisition of ketamine self-administration in rats

Marco Vènniro, Anna Mutti, Cristiano Chiamulera · Psychopharmacology · 2015 · 30 citations

Molecular Pharmacology, Non-pharmacological Factors, Pharmacological Study +11

The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission

Anna Mutti, Sonia Aroni, Paola Fadda et al. · Psychopharmacology · 2016 · 22 citations

Self-administration Paradigm, Neurophysiology, Addiction +10